T3	Effect 0 2	MI
T5	Treatment 25 57;191 228	activated and non-activated PCCs large cumulative doses of concentrate
T6	Subject 80 158	young patients who often have no preceding history of, or risk factors for, MI
T7	Age 80 85	young
T8	Drug 39 57	non-activated PCCs
T9	Dosage 191 213	large cumulative doses
T10	Drug 25 34;53 57	activated PCCs
T4	Adverse_event 3 10	related
E1	Adverse_event:T4